TD Cowen raised the firm’s price target on Universal Health to $220 from $183 and keeps a Hold rating on the shares. The firm said they had a strong quarter with Acute EBITDA by 3% and Psych 18% over consensus and noted revenue guidance was raised.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- UHS Earnings: Universal Health Jumps after Huge EPS, Guidance Beats
- UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES 2024 SECOND QUARTER FINANCIAL RESULTS, INCREASES 2024 FULL YEAR OPERATING RESULTS FORECAST AND ANNOUNCES $1 BILLION INCREASE TO STOCK REPURCHASE PROGRAM AUTHORIZATION
- Universal Health raises FY24 adjusted EPS view to $15.40-$16.20
- Universal Health reports Q2 adjusted EPS $4.31, consensus $3.28
- Notable companies reporting after market close